000			a
999			_c16970 _d16970
003			OSt
005			20220629145404.0
008			220629b xxu||||| |||| 00| 0 eng d
040			_aAIKTC-KRRC _cAIKTC-KRRC
100			_916909 _aSathyaprabha, G.
245			_aSociodemographic characteristics of inflammatory bowel disease: an observational study at multispeciality hospital
250			_aVol.15(4), Oct-Dec
260			_aM P _bBRNSS Publication Hub. _c2021
300			_a394-399p.
520			_aBackground: The chronic inflammation in the gastrointestinal tract is characterized by the non-infectious conditions of inflammatory bowel disease (IBD) characterised as Crohn’s disease and ulcerative colitis caused by the abnormal immune response. Indian statistical report states that world has exceeded 12 lakhs cases annually due to poor awareness about the disease seriousness. Purpose: This study aimed to determine the outcomes in sociodemographic characteristics of IBD at a multi-specialty hospital in South India. Materials and Methods: This was a hospital-based cross-sectional observational study conducted among 69 individuals attending the gastroenterology department with IBD from November 2018 to February 2020 by a convenient sampling method. The questionnaire was used to analyze the sociodemographic variables by the statistical package of SPSS 20 version. Results: The study explored from 69 patients was diagnosed with a mean age of 36.75 ± 0.827 and ratio of females to male (0.8:0.6), urban patients with 27.5 ± 4.157, in graduates of 15 ± 3.045, 4.3% of positive family history, smoking 6.5 ± 1.953, alcoholism 7 ± 2.034, business as an occupation in 9.5 ± 2.397 and food habits with 21 ± 3.622. Conclusion: Further suggest for more studies in IBD to have a better understanding of sociodemographic factors. Gender was significant, age of the patient, family history, and smoking habits with less than *p < 0.05 but remaining variables were found to be controversial from other studies. This information may be used to establish various strategic measures to prevent and control inflammatory disease. The current study will be useful for policymakers and healthcare professionals to frame the protocols for future perspectives.
650		0	_94755 _aPHARMACOGNOSY
700			_916910 _aSrinivasan, N.
773	0		_tInternational journal of green pharmacy _dMandsaur B.R. Nahata Smriti Sansthan
856			_uhttps://www.greenpharmacy.info/index.php/ijgp/article/view/3186 _yClick here
942			_2ddc _cAR